Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders

G. Sanacora, H. Heimer, D. Hartman, S. J. Mathew, Mark A Frye, C. Nemeroff, R. Robinson Beale

Research output: Contribution to journalComment/debate

15 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1179-1181
Number of pages3
JournalNeuropsychopharmacology
Volume42
Issue number6
DOIs
StatePublished - May 1 2017

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Sanacora, G., Heimer, H., Hartman, D., Mathew, S. J., Frye, M. A., Nemeroff, C., & Robinson Beale, R. (2017). Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders. Neuropsychopharmacology, 42(6), 1179-1181. https://doi.org/10.1038/npp.2016.193

Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders. / Sanacora, G.; Heimer, H.; Hartman, D.; Mathew, S. J.; Frye, Mark A; Nemeroff, C.; Robinson Beale, R.

In: Neuropsychopharmacology, Vol. 42, No. 6, 01.05.2017, p. 1179-1181.

Research output: Contribution to journalComment/debate

Sanacora, G, Heimer, H, Hartman, D, Mathew, SJ, Frye, MA, Nemeroff, C & Robinson Beale, R 2017, 'Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders', Neuropsychopharmacology, vol. 42, no. 6, pp. 1179-1181. https://doi.org/10.1038/npp.2016.193
Sanacora G, Heimer H, Hartman D, Mathew SJ, Frye MA, Nemeroff C et al. Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders. Neuropsychopharmacology. 2017 May 1;42(6):1179-1181. https://doi.org/10.1038/npp.2016.193
Sanacora, G. ; Heimer, H. ; Hartman, D. ; Mathew, S. J. ; Frye, Mark A ; Nemeroff, C. ; Robinson Beale, R. / Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders. In: Neuropsychopharmacology. 2017 ; Vol. 42, No. 6. pp. 1179-1181.
@article{f16ac766c2d3484bb9738713dba8b505,
title = "Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders",
author = "G. Sanacora and H. Heimer and D. Hartman and Mathew, {S. J.} and Frye, {Mark A} and C. Nemeroff and {Robinson Beale}, R.",
year = "2017",
month = "5",
day = "1",
doi = "10.1038/npp.2016.193",
language = "English (US)",
volume = "42",
pages = "1179--1181",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders

AU - Sanacora, G.

AU - Heimer, H.

AU - Hartman, D.

AU - Mathew, S. J.

AU - Frye, Mark A

AU - Nemeroff, C.

AU - Robinson Beale, R.

PY - 2017/5/1

Y1 - 2017/5/1

UR - http://www.scopus.com/inward/record.url?scp=84991030713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991030713&partnerID=8YFLogxK

U2 - 10.1038/npp.2016.193

DO - 10.1038/npp.2016.193

M3 - Comment/debate

C2 - 27640324

AN - SCOPUS:84991030713

VL - 42

SP - 1179

EP - 1181

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 6

ER -